ED
BHI

Exane Derivatives’s Baker Hughes BHI Stock Holding History

Exane Derivatives’s Portfolio BHI Stock Details BHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,531
Closed -$83.4K – 674
2017
Q2 		$83.4K Buy
1,531
+231
+18% +$13.3K 0.02% 287
2017
Q1 		$77.8K Buy
1,300
+333
+34% +$20.3K 0.02% 241
2016
Q4 		$62.8K Sell
967
-504
-34% -$29.9K 0.01% 279
2016
Q3 		$74.2K Sell
1,471
-211
-13% -$10.2K 0.01% 262
2016
Q2 		$75.9K Buy
1,682
+808
+92% +$36.6K 0.01% 256
2016
Q1 		$38.3K Buy
+874
New +$37.7K 0.01% 340
2015
Q4 		– Sell
-687
Closed -$35.8K – 582
2015
Q3 		$35.8K Sell
687
-108
-14% -$6.03K ﹤0.01% 293
2015
Q2 		$49K Hold
795
– – 0.01% 290
2015
Q1 		$50.5K Buy
795
+606
+321% +$36.6K 0.01% 314
2014
Q4 		$10.6K Buy
+189
New +$10.7K ﹤0.01% 410

Other funds holding BHI

AIM
Artemis Investment Management Edinburgh, United Kingdom $9.43B AUM 69.06% 1-Year Est. Return
LHC
Levy Harkins & Co New York $393M AUM 26.94% 1-Year Est. Return
GIBU
Gulf International Bank (UK) London, United Kingdom $4.47B AUM 29.35% 1-Year Est. Return
SBA
Seven Bridges Advisors New York $9.75M AUM 16.73% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
TCA
Tortoise Capital Advisors Overland Park, Kansas $9.6B AUM 19.53% 1-Year Est. Return

Exane Derivatives's BHI Position: Q3 2017 in Review

Exane Derivatives sold out of Baker Hughes (BHI) in Q3 2017, closing a stake of 1,531 shares — an estimated $83.4K sold.

Exane Derivatives first reported a position in BHI in Q4 2014 and held it in 10 quarters. The position peaked at $83.4K in Q2 2017. 7 funds tracked by Wall St. Rank hold BHI as of Q3 2017.

  • Exane Derivatives reported no remaining Baker Hughes position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1,531 Baker Hughes shares in Q3 2017, an estimated $83.4K.
  • Exane Derivatives first reported a position in Baker Hughes in Q4 2014 and held it in 10 quarters.
  • Exane Derivatives's Baker Hughes position peaked at $83.4K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Baker Hughes as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.